GlassScriptPhysician profile
Lane M Lee
NPI 1073600979
$11,191.70
in general payments reported to CMS, 2019-2025
16 companies · $2,831 in 2025
The $2,831 reported for 2025 was more than what 77% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,718 · 2020: $556 · 2021: $1,245 · 2022: $1,130 · 2023: $615 · 2024: $1,097 · 2025: $2,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,233 · Travel and Lodging: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,233.27 |
| Travel and Lodging | $1,309.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $4,479.07 | 2019-2025 | Endocross Device, Torus Stent Graft System, Afx2 Bifurcated Endograft System |
| Philips North America LLC | $2,046.50 | 2019-2024 | (P84) Igt Devices Systems |
| Medtronic Vascular, INC. | $1,423.97 | 2019 | |
| Abbott Laboratories | $529.89 | 2024-2025 | Xact, Esprit |
| Boston Scientific Corporation | $509.62 | 2019-2024 | Eluvia |
| Silk Road Medical, INC. | $425.76 | 2020-2022 | |
| Cagent Vascular INC | $332.28 | 2025 | Serrantor |
| W. L. Gore & Associates, INC. | $321.35 | 2021-2024 | C3 Delivery System |
| Medtronic, INC. | $284.64 | 2021-2024 | Endurant Iis |
| Shockwave Medical, INC | $282.92 | 2021-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Bard Peripheral Vascular, INC. | $251.88 | 2019 | |
| Cook Medical LLC | $129.53 | 2019-2020 | |
| Venturemed Group, INC. | $102.90 | 2021 | |
| Cordis US Corp. | $46.19 | 2022-2023 | Rain Sheath Transradial |
| Lemaitre Vascular, INC. | $13.89 | 2025 | Restoreflow |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lane Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.